-
IPO Update: AN2 Therapeutics Seeks $60 Million U.S. IPO
22 Mar 2022 08:50 GMT
… VP Neglected Diseases at Anacor Pharmaceuticals, a firm that … Technology Fund, RA Capital, Anacor Pharmaceuticals (Pfizer), Brii Biosciences, Biotechnology … ’s enterprise value at IPO (excluding underwriter options) … the lead underwriter and IPOs led by the …
-
AN2 Therapeutics Files For U.S. IPO
08 Mar 2022 19:08 GMT
… VP Neglected Diseases at Anacor Pharmaceuticals, a firm that was … Technology Fund, RA Capital, Anacor Pharmaceuticals (Pfizer), Brii Biosciences, Biotechnology … Listed bookrunners of the IPO are Cowen, SVB Leerink, … the lead underwriter and IPOs led by the firm …
-
Evolution Of The Biotech IPO Markets From Busted To Booming
21 Sep 2020 13:06 GMT
… painful: for example, Anacor, acquired later for $ … IPOs today, and hence valuation appreciation.
So what changed in the IPO … conviction about an upcoming IPO.
Furthermore, bankers competing … structural change: virtual IPO roadshow?
While crossover …
-
Tricida IPO: Almost Completed Phase 3 And A Massive Total Addressable Market
08 Jul 2018 20:44 GMT
… management bring expertise accumulated in Anacor Pharmaceuticals, Inc., Goldman Sachs … the case in pharma IPOs, the company shows stable … much better after the IPO. All the outstanding convertible … IPO, or Eidos (EIDX) IPO for some other examples of pharma IPOs …
-
We're Hesitant On AnaptysBio's IPO
24 Jan 2017 14:21 GMT
… previewed this deal on our IPO Insights platform. AnaptysBio will … ), Sanofi (NYSE:SNY), and Anacor (NASDAQ:ANAC). Executive Management Highlights … this upcoming IPO. Don Dion's IPO Insights provides … and analysis on the major IPOs each week, along with …
-
Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team
03 Aug 2023 13:07 GMT
… , Inc., where he led its initial public offering and multiple equity and debt … strategy/portfolio planning at Anacor (acquired by Pfizer), Forest (now …
-
Lung-Disease Focused AN2 Therapeutics Files Plans For NASDAQ Debut
07 Mar 2022 20:15 GMT
… to go public in an initial public offering in which it reportedly hopes … weakened immune system.
See the IPO prospectus here.
Its initial product … commercialization rights for epetraborole from Anacor Pharmaceuticals, owned by Pfizer Inc (NYSE …
-
Apollomics, Inc. Strengthens Leadership with Key Hires
22 Jan 2019 12:50 GMT
… provider, and led their Nasdaq Initial Public Offering as CFO. Prior to Velti … was VP, Clinical Operations of Anacor Pharmaceuticals where she had oversight for … Clinical Operations department. Prior to Anacor, Dr. Vallner was VP, Clinical …
-
Upcoming Earnings: Pfizer Reports Tomorrow As Management Explores Alternatives For Consumer Healthcare
30 Oct 2017 17:53 GMT
… business, Zoetis (ZTS), through an initial public offering in 2013.
Amid slowing and … of August. Recent acquisitions include Anacor Pharmaceuticals for $5.2 billion in …
-
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results
14 Mar 2017 11:15 GMT
… , France. Completed a successful initial public offering, securing a strong cash position … Graeme Bell, formerly CFO of Anacor Pharmaceuticals (acquired by Pfizer in 2016 … to proceeds from our initial public offering and concurrent private placements …